journal article·2022-12-28

Synergistically Enhancing Tumor Chemotherapy Using an Aggregation-Induced Emission Photosensitizer on Covalently Conjugated Molecularly Imprinted Polymer Nanoparticles

Haizhu Shi, Yu Wan, Xiao Tian, Lijuan Wang, Lianhai Shan, Chungu Zhang, Ming-Yu Wu, Shun Feng

ACS Applied Materials & Interfaces· Volume 14· Issue 51
Publisher page

Abstract

Due to the polygenic and heterogeneous nature of the tumorigenesis process, traditional chemotherapy is far from desirable. Fabricating multifunctional nanoplatforms integrating photodynamic effect can synergistically enhance chemotherapy because they can make the cancer cells much sensitive to chemotherapeutics. However, how to assemble different units in nanoplatforms and minimize side effects caused by chemodrugs and photosensitizers (PSs) still needs to be explored. Herein, a nanoplatform CPP/PS-MIP@DOX is developed using a simultaneously covalently conjugated new aggregation-induced emission (AIE) PS and a cell-penetrating peptide (CPP) on the surface of silica-based molecularly imprinted polymer (MIP) nanoparticles, prepared with doxorubicin (DOX) as the template in the water system via a sol-gel technique. CPP/PS-MIP@DOX has good biocompatibility, high DOX-loading ability, promoted cellular uptake, and sustained and pH-sensitive drug release capability. Furthermore, it can efficiently penetrate into tumor tissue, accurately home to, and accumulate at the tumor site. As a result, a better efficacy with lower cytotoxicity is achieved with a smaller dosage of DOX by utilizing either the photodynamic effect or unique characteristics of the MIP. It is the first nanoplatform fabricated by chemically conjugating AIE PSs directly on the surface of the scaffold via the surface-decorated strategy and successfully applied in cancer therapy. This work provides an effective strategy by constructing AIE PS-based cancer nanomedicines with MIPs as scaffolds.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China

Funding

Central University Basic Research Fund of China · Basic Research Programs of Sichuan Province · National Natural Science Foundation of China

References (56)

Show source-provided references
1. 10.1002/adfm.20210460710.1002/adfm.202104607 ↗
2. 10.1021/acsami.1c0306510.1021/acsami.1c03065 ↗
3. 10.1016/j.jconrel.2017.06.02210.1016/j.jconrel.2017.06.022 ↗
4. 10.1021/acsnano.8b0616410.1021/acsnano.8b06164 ↗
5. 10.1002/anie.20190088610.1002/anie.201900886 ↗
6. 10.1021/acsnano.2c0252810.1021/acsnano.2c02528 ↗
7. 10.1021/acsnano.1c0858510.1021/acsnano.1c08585 ↗
8. 10.1021/cr500419810.1021/cr5004198 ↗
9. 10.1002/adma.20220151610.1002/adma.202201516 ↗
10. 10.1002/anie.20180881110.1002/anie.201808811 ↗
11. 10.1002/anie.20201735010.1002/anie.202017350 ↗
12. 10.1021/acsnano.1c1077010.1021/acsnano.1c10770 ↗
13. 10.1021/acsnano.0c0940710.1021/acsnano.0c09407 ↗
14. 10.1002/adfm.20220050310.1002/adfm.202200503 ↗
15. 10.1002/adma.20210374810.1002/adma.202103748 ↗
16. 10.1002/anie.20211212810.1002/anie.202112128 ↗
17. 10.1002/adfm.20201024110.1002/adfm.202010241 ↗
18. 10.1021/acs.macromol.1c0127610.1021/acs.macromol.1c01276 ↗
19. 10.1016/j.cej.2018.09.07710.1016/j.cej.2018.09.077 ↗
20. 10.1021/acsami.6b0444210.1021/acsami.6b04442 ↗
21. 10.1002/adfm.20200591810.1002/adfm.202005918 ↗
22. 10.1039/D0TB01669A10.1039/D0TB01669A ↗
23. 10.1016/j.ccr.2017.09.00610.1016/j.ccr.2017.09.006 ↗
24. 10.1021/acsami.8b0554610.1021/acsami.8b05546 ↗
25. 10.1021/acs.chemrev.5b0026310.1021/acs.chemrev.5b00263 ↗
26. 10.1016/j.biomaterials.2017.09.00410.1016/j.biomaterials.2017.09.004 ↗
27. 10.1002/smll.20210177010.1002/smll.202101770 ↗
28. 10.1002/advs.20210052410.1002/advs.202100524 ↗
29. 10.1021/acsnano.8b0313810.1021/acsnano.8b03138 ↗
30. 10.1002/anie.20220721310.1002/anie.202207213 ↗
31. 10.1039/C2NR32698A10.1039/C2NR32698A ↗
32. 10.1039/C9QM00081J10.1039/C9QM00081J ↗
33. 10.1039/C6SC00036C10.1039/C6SC00036C ↗
34. 10.1073/pnas.161683611310.1073/pnas.1616836113 ↗
35. 10.1021/acsnano.7b0308810.1021/acsnano.7b03088 ↗
36. 10.3390/cancers1106075310.3390/cancers11060753 ↗
37. 10.1002/adfm.20160653010.1002/adfm.201606530 ↗
38. 10.1021/acs.chemrev.0c0042810.1021/acs.chemrev.0c00428 ↗
39. 10.1007/s00216-021-03409-110.1007/s00216-021-03409-1 ↗
40. 10.1021/acs.chemrev.8b0017110.1021/acs.chemrev.8b00171 ↗
41. 10.1021/acs.analchem.0c0495910.1021/acs.analchem.0c04959 ↗
42. 10.1002/anie.20200530910.1002/anie.202005309 ↗
43. 10.1021/am403942y10.1021/am403942y ↗
44. 10.1002/adma.20210054310.1002/adma.202100543 ↗
45. 10.1021/acs.analchem.9b0212310.1021/acs.analchem.9b02123 ↗
46. 10.1021/acsami.1c1138810.1021/acsami.1c11388 ↗
47. 10.1021/acsami.9b1153310.1021/acsami.9b11533 ↗
48. 10.1039/C9NR09687F10.1039/C9NR09687F ↗
49. 10.1007/s11426-021-1199-610.1007/s11426-021-1199-6 ↗
50. 10.1039/D2SC00067A10.1039/D2SC00067A ↗
51. 10.1039/C9NR04655K10.1039/C9NR04655K ↗
52. 10.1016/j.addr.2021.11404410.1016/j.addr.2021.114044 ↗
53. 10.3390/cancers1201016510.3390/cancers12010165 ↗
54. 10.1016/j.ijpharm.2017.10.02310.1016/j.ijpharm.2017.10.023 ↗
55. 10.1002/anie.20150306610.1002/anie.201503066 ↗
56. 10.1021/ac034531s10.1021/ac034531s ↗